TS
BDSX icon

Thomas Steyer’s Biodesix BDSX Stock Holding History

Thomas Steyer’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-6,400
Closed -$36.1K – 150
2025
Q2 		$36.1K Sell
6,400
-86,565
-93% -$699K ﹤0.01% 142
2025
Q1 		$1.16M Sell
92,965
-97,606
-51% -$1.87M 0.01% 92
2024
Q4 		$5.83M Sell
190,571
-41,269
-18% -$1.21M 0.03% 86
2024
Q3 		$8.25M Buy
231,840
+137,931
+147% +$4.74M 0.04% 88
2024
Q2 		$2.87M Buy
+93,909
New +$2.68M 0.01% 99

Other funds holding BDSX

TAM
Telemark Asset Management Boston, Massachusetts $1.38B AUM 71.45% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $59.6M AUM 181.61% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Thomas Steyer's BDSX Position: Q3 2025 in Review

Thomas Steyer sold out of Biodesix (BDSX) in Q3 2025, closing a stake of 6,400 shares — an estimated $36.1K sold.

Thomas Steyer first reported a position in BDSX in Q2 2024 and held it in 5 quarters. The position peaked at $8.25M in Q3 2024. 26 funds tracked by Wall St. Rank hold BDSX as of Q3 2025.

  • Thomas Steyer reported no remaining Biodesix position as of Q3 2025 after selling out during the quarter.
  • Thomas Steyer sold 6,400 Biodesix shares in Q3 2025, an estimated $36.1K.
  • Thomas Steyer first reported a position in Biodesix in Q2 2024 and held it in 5 quarters.
  • Thomas Steyer's Biodesix position peaked at $8.25M in Q3 2024.
  • 26 funds tracked by Wall St. Rank held Biodesix as of Q3 2025.

Based on Farallon Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.